08/13/2025
4:11 PM | Theravance Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/16/2025
5:01 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2025
3:03 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2025
5:05 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2025
5:06 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2025
5:16 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
5:03 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2025
5:04 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
3:25 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/02/2025
5:02 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2025
5:39 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TBPH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
05/22/2025
5:41 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
5:42 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
5:44 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
6:00 PM | Smaldone Alsup Laurie (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
6:02 PM | BROSHY ERAN (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
6:10 PM | Grant Jeremy T (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
6:13 PM | GRAY SUSANNAH (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
6:15 PM | MITCHELL DEAN J (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
6:17 PM | O'Connor Donal (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
6:20 PM | PAKIANATHAN DEEPIKA (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
6:22 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2025
3:29 PM | Theravance Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2025
5:00 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2025
4:16 PM | Theravance Biopharma (Filer)
| Form DEF 14A | |
03/07/2025
5:15 AM | Theravance Biopharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2025
5:17 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:07 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:09 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:11 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:05 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
6:24 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
6:26 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
6:28 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
6:30 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
6:32 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
5:05 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
5:04 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
5:06 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
5:08 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
5:09 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad) Something big is brewing in Washington.
According to my research, an executive order from President Trump could be just weeks away.
And it holds the potential to trigger one of the most explosive tech booms in US history.
At the center of it all? Robots.
Not the kind that clean your house or pour you coffee.
But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year. This little-known company holds nearly 100 patents and trades for around $7 |
11/22/2024
5:10 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:08 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
8:53 AM | Madison Avenue Partners, LP (Filed by)
Theravance Biopharma (Subject)
| Form SC 13G/A | |
11/14/2024
5:06 AM | Theravance Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
7:42 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
2:33 PM | Theravance Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
1:10 PM | Theravance Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/24/2024
3:44 PM | BlackRock, Inc. (Filed by)
Theravance Biopharma (Subject)
| Form SC 13G/A | |
09/23/2024
5:05 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
5:02 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
4:42 PM | BAUPOST GROUP LLC/MA (Filed by)
Theravance Biopharma (Subject)
| Form SC 13G/A | |
08/22/2024
7:03 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:05 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:06 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:07 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:09 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
MarketBeat All Access